(Q35015659)

5 August 2017

The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice (English)

1 reference

5 August 2017

13

1 reference

5 August 2017

5

Henna Karvinen

1 reference

5 August 2017

1

Jenni Huusko

1 reference

5 August 2017

6

Tuomas T Rissanen

1 reference

5 August 2017

Maarten Vanwildemeersch

7

object named as

Maarten Vanwildemeersch

1 reference

5 August 2017

10

Suvi E Heinonen

1 reference

5 August 2017

2

Mari Merentie

1 reference

5 August 2017

8

Marja Hedman

1 reference

5 August 2017

3

Marike H Dijkstra

1 reference

5 August 2017

Minttu-Maria Ryhänen

4

1 reference

5 August 2017

Jukka Lipponen

9

1 reference

5 August 2017

Ulf Eriksson

11

1 reference

5 August 2017

Masabumi Shibuya

12

1 reference

5 August 2017

2 December 2009

1 reference

5 August 2017

Cardiovascular Research

1 reference

5 August 2017

86

1 reference

5 August 2017

1

1 reference

5 August 2017

122-130

1 reference

Current status of cardiovascular gene therapy

5 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

The biology of vascular endothelial growth factor-B (VEGF-B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factor-B promotes in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

High-resolution ultrasound perfusion imaging of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP382

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP382

1 reference

5 August 2017

1 reference